NCT00143091 - Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive Disorder | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

April 30, 2006

Conditions

Depressive Disorder, Major

Interventions

DRUG

CP-316,311

DRUG

Placebo

DRUG

Sertraline

Trial Locations (10)

Pfizer Investigational Site, Bellevue

Pfizer Investigational Site, Seattle

Pfizer Investigational Site, Moscow

Pfizer Investigational Site, Rostov-on-Don

Pfizer Investigational Site, Saint Petersburg

Pfizer Investigational Site, Smolensk

Pfizer Investigational Site, Belgrade

Pfizer Investigational Site, Kragujevac

Pfizer Investigational Site, Novi Sad

Pfizer Investigational Site, Belgrade